Biochemical markers for acute pulmonary embolism
US8501155B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2009 |
| Grant date | Aug 6, 2013 |
| Priority date | — |
| Expiry date | May 28, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/12
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a method of differentiating between a singular and a multiple lung embolism in a subject suspected to suffer from acute lung embolism comprising determining the amount of NT-proBNP in a sample of a subject suspected to suffer from acute lung embolism and comparing the amount to a reference amount. Further, the present invention also relates to a method of differentiating between acute and chronic lung embolism in a subject comprising determining the amount of NT-proANP at a first and a second time point and comparing the determined amounts with each other. The present invention also encompasses devices and kits for carrying out the aforementioned methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.